Die Grafik zeigt die prognostizierten Quartalsgewinne (Bereinigter Gewinn pro Aktie, EPS) und die tatsächlich erzielten Gewinne (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Umsatz (USD)
Schätzung
Umsatz
Die Grafik zeigt die prognostizierten Quartalsumsätze und die tatsächlich erzielten Umsätze (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Güte der Analystenschätzungen – EPS (aktueller Zeitraum)
Quartal / Datum
EPS (USD)
Schätzung (USD)
Abweichung
Quartal / Datum
Umsatz (Mio USD)
Schätzung (Mio USD)
Abweichung
Revisionen der Gewinnschätzungen
EPS-Schätzungen für die Geschäftsjahre
2027, 2028, 2029.
Taylor Devices remains undervalued despite record-high backlog, with the market yet to fully reflect its improved fundamentals. Backlog surged from $20.8M to $55.2M, driven by robust, diversified demand across all product groups amid global geopolitical unrest. Recent EPS declined to $2.14, but the market anticipates a rebound as backlog converts to revenue; current price return suggests optimism.
Taylor Devices reported another weak quarter but maintains a record $55.2M backlog, signaling strong demand. Despite a 26% YoY revenue decline and a 44% revenue miss, strong operating cash flow and working capital shifts suggest unrecognized project activity. I see the revenue shortfall as a timing issue, not a demand problem, and expect backlog conversion to drive a sharp earnings rebound.
Taylor Devices, Inc. (TAYD) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.7 per share a year ago.
NORTH TONAWANDA, N.Y., Oct. 2, 2026 /PRNewswire/ -- Taylor Devices, Inc. (NASDAQ SmallCap: "TAYD") announced today that it had first quarter sales of $7,300,239, down from last year's first quarter sales of $9,918,350.
On September 30, 2026, Taylor Devices Inc (TAYD) shares fell 3.1% to $61.01, moving within a 52-week range of $40.50 to $90.37. This recent decline highlights t
Taylor Devices remains a Buy despite a weak FY2026, as a record $52.8M backlog signals delayed orders are now converting. The 154% sequential backlog surge, even excluding a $19M one-off order, supports management's claim that demand remains robust. 92% of the backlog is tied to Aerospace & Defense, providing revenue visibility and margin stability for FY2027.
Markets are clawing back from a brutal Thursday selloff, but the real action is in the analyst calls, where BMO Capital just pulled the trigger on three major chip stocks at once and DZ Bank opened SpaceX coverage with a Sell.
Portfolios
0
Zum Anlegen oder Bearbeiten von Portfolios müssen Sie sich anmelden oder einen Account erstellen.
Aktuelle Aktie in ein Portfolio speichern oder neues Portfolio anlegen: